Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN1203040C. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1203040C details a mild Cu-catalyzed Ullmann ether synthesis using amino acid ligands, offering cost-effective scale-up for pharmaceutical intermediates.